Tirzepatide for Weight Loss: The Complete Guide

Tirzepatide has quickly become one of the most talked-about active ingredients in weight management medication. If you have been reading about it and want to understand what it actually is, how it produces the results people describe, and what treatment involves in practice, this guide walks through the essentials - from the biology behind it to the day-to-day realities of using it.

A quick definition - what is tirzepatide?

Tirzepatide (spoken “tir-ZEP-a-tide”) is a prescription-only medicine licensed to help manage obesity and type 2 diabetes. In the UK it reaches patients under the brand name Mounjaro, and it is given as a single injection under the skin once a week.

What sets it apart from earlier weight-loss injections is its reach inside the body. Most medicines of this kind work through one hormone pathway; tirzepatide switches on two at the same time - the receptors for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Because it engages both, pharmacologists describe it as a dual agonist: a single molecule that activates two different hormone receptors together [2].

The biology: why acting on two hormones matters

GIP and GLP-1 are gut hormones. Your intestine releases them after you eat, and both play a part in keeping blood sugar steady, dialling down appetite, and telling the brain you have had enough - the sensation of satiety. Tirzepatide mimics both at once, so those signals are turned up together: hunger falls, glucose is handled more efficiently, and the full feeling after a meal lingers longer [2].

That combined action is widely thought to explain why tirzepatide often outperforms medicines that rely on a single receptor - semaglutide among them, the active ingredient in Wegovy injections and the Wegovy pill, which works through GLP-1 alone [5,6].

What tirzepatide is licensed to treat

In adults, tirzepatide has two approved roles. The first is helping to control type 2 diabetes. The second is supporting sustained weight management, either in people living with obesity or in those carrying excess weight alongside a related health problem such as raised blood pressure, high cholesterol, or sleep apnoea.

How much weight can it help you lose?

On the evidence available, tirzepatide sits among the most effective medicines yet developed for obesity.

The headline figure comes from the SURMOUNT-1 trial: at the top maintenance dose of 15mg a week, participants shed an average of up to 22.5% of their starting body weight across 72 weeks, against just 3.1% for those given a placebo [1].

Inside the SURMOUNT-1 trial

SURMOUNT-1 was a large randomised controlled trial reported in the New England Journal of Medicine in 2022. It recruited 2,539 adults - everyone had a BMI of 30 or higher, or 27 or higher with at least one weight-related condition (type 2 diabetes aside) - and pitted three active doses of tirzepatide against a placebo over 72 weeks. Throughout, all participants also received support with diet and physical activity [1].

Weight loss by dose broke down as follows:

Beyond the raw numbers, the trial reported several other findings:

• Many participants described gains in physical functioning, emotional wellbeing, and overall quality of life.
• Around 57% of those on the 10mg or 15mg dose reached weight loss of 20% or more, compared with 3% on placebo.
• Roughly 91% of people on tirzepatide lost at least 5% of their starting weight, versus 35% on placebo.
• Blood pressure and waist circumference both fell - two recognised markers of cardiovascular risk.
• The commonest side effects were gastrointestinal - nausea, vomiting, diarrhoea and constipation - and only about 4–7% of participants stopped because of them.

When will you notice a difference?

Most people find their appetite eases within the first few weeks. Visible changes on the scales tend to follow at around four to eight weeks, but the substantial results build slowly: in the trials, the biggest reductions came after a full 72 weeks of continuous treatment. Because Mounjaro is stepped up gradually - starting at 2.5mg and rising every four weeks - the medicine reaches its full effect over months rather than days. Pairing it consistently with a lower-calorie diet and more activity gives you the best chance of a strong result.

How long does tirzepatide stay in your body?

Tirzepatide has a half-life of roughly five days - that is, five days for the amount in your body to drop by half. Working from that, it takes somewhere between 25 and 30 days (about five half-lives) for the drug to clear completely once you have had your final dose.

This long half-life is exactly why the injection is only needed weekly: it holds a steady level of medicine in the bloodstream from one dose to the next. In day-to-day terms, though, the appetite and blood-sugar effects usually fade within a week or two of a missed dose, even while small traces linger longer. Stop altogether, and your appetite, glucose levels and weight tend to drift back toward where they began over the following weeks to months.

Tirzepatide compared with other weight-loss medicines

Several prescription weight-loss options are now on the market in the UK, and picking between them is rarely clear-cut.

The best fit depends on your medical history, any conditions you already have, the other medicines you take, and what you personally prefer. A Bliss clinician can help you weigh it up. Points worth thinking through include:

• Whether you would rather take a tablet or an injection
• Your general health and any other conditions
• How you got on with any previous weight-management treatments, side effects included
• Your current medicines and the potential for interactions
• Your family medical history
• The ongoing cost of each option

Tirzepatide versus semaglutide

The figures above are drawn from SURMOUNT-5 [6], the first head-to-head study to compare tirzepatide and semaglutide directly - 751 adults with obesity (but without type 2 diabetes), followed over 72 weeks, with both medicines titrated to the highest tolerated dose. In that same trial, 19.7% of people on tirzepatide lost at least 30% of their body weight, against 6.9% on semaglutide.

Could tirzepatide be right for you?

Whether you qualify depends partly on the route - the NHS and a private provider such as Bliss apply different criteria.

Through a private provider

If you are supplied tirzepatide privately, choose a regulated pharmacy so you know your care is in accredited hands. Bliss is registered with the General Pharmaceutical Council (GPhC number 2064448), the body that regulates pharmacy professionals and pharmacies across Great Britain.

Through the NHS

An NHS prescription generally starts with a GP referral to a specialist weight-management service, and you will normally need to meet set clinical criteria [3,4]:

• A BMI of 40 or above, or 35 or above with at least one weight-related condition such as type 2 diabetes, high blood pressure, sleep apnoea, raised cholesterol, or cardiovascular disease.
• A lower BMI threshold of 27.5 may apply to people from certain ethnic backgrounds - including South Asian, Chinese, other Asian, Middle Eastern, Black African and African-Caribbean communities; reflecting evidence that weight-related health risks appear at a lower BMI in these groups.

When tirzepatide is not an option

There are situations where tirzepatide must not be used at all - it is contraindicated - including [2]:

• A known allergy to tirzepatide or any of its excipients.
• A personal or first-degree family history of medullary thyroid carcinoma (MTC).
• Pregnancy. If you are planning to conceive, stop tirzepatide at least a month beforehand, and contact your prescriber straight away if you fall pregnant while taking it.
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
• Breastfeeding.

It also calls for caution, and may not be suitable, if you have a history of:

• Severe gastroparesis or other significant problems with stomach motility
• Diabetic retinopathy or macular oedema
• Heart, liver or kidney disease, particularly if severe
• Pancreatitis (inflammation of the pancreas)
• An eating disorder

Whatever your situation, give your doctor or pharmacist the full picture before you begin - your complete medical history, every medicine you take (supplements and over-the-counter products included), and any allergies.

Living with treatment: doses, injections and storage

The dosing schedule

Everyone starts tirzepatide at 2.5mg a week, whatever their eventual target. From there the dose climbs in 2.5mg steps, usually every four weeks, until you settle on a maintenance dose. Which one - 5mg, 10mg or 15mg a week - depends on how you respond and how you tolerate it. The highest licensed dose is 15mg [2].

If you miss a dose

What to do hinges on how long ago the injection was due [2]:

• Within four days (96 hours): inject as soon as you remember, then carry on with your usual weekly day.
• More than four days: skip that dose entirely and take the next one on your normal day.

Never double up within a single week to make up for a missed injection. If you have missed more than one, or you are simply not sure, check with your pharmacist or prescriber first.

Taking the injection

Tirzepatide goes in as a subcutaneous (under-the-skin) injection, once a week [2]. Your prescriber or pharmacist will run through the technique before your first dose, and full instructions come in the patient information leaflet with your medicine.

A few general pointers:

• Inject on the same day each week; if you need to shift the day, leave at least three days between doses.
• Wipe the site with an alcohol swab and let it dry before injecting.
• Wash and dry your hands before you handle the pen.
• Pinch the skin gently, put the needle in at a 90-degree angle, and press the plunger down steadily.
• You can inject at any time of day, with or without food.

There are three areas you can use [2]:

1. Abdomen - the fatty part of your stomach, keeping at least 5cm (2 inches) from your navel
2. Upper thigh - the front or outer surface of either thigh
3. Upper arm - the outer, fleshy part

Move around from week to week - alternating abdomen and thigh, for instance - and shift the exact spot within each area so you are not irritating the same tissue repeatedly. Steer clear of skin that is sore, bruised, red, swollen, hardened or broken, and avoid injecting over scars or stretch marks where you can. If you are ever unsure of your technique or which site to pick, ask your pharmacist or prescriber to talk it through before you start.

Storing and disposing of your pens

Mounjaro pens belong in the fridge at 2–8°C until you first use them. Once out, they can sit at room temperature (below 30°C) for up to 30 days. Do not freeze them, and keep them out of direct sunlight; the patient information leaflet has the full storage detail [2]. Unopened pens keep in the fridge, at 2–8°C, right up to the expiry date printed on the pen.

Because each pen contains a needle, used pens cannot go in your household bin or recycling; they need an approved sharps container [11]. Sharps bins are free on prescription from your GP or pharmacist. When one is full, your local council can arrange collection, or a participating pharmacy will take it back; the NHS website has more guidance.

Tirzepatide side effects and safety

Like any medicine, tirzepatide can cause side effects. For most people they are mild and settle as the body adjusts; the dose-escalation phase is when they tend to show up most. If anything is troublesome, getting worse, or refusing to clear, see your GP.

Common side effects include:

• Hair loss
• Fatigue
• Bloating
• Diarrhoea
• Nausea (feeling sick)
• Vomiting (being sick)
• Constipation
• Indigestion and acid reflux
• Dizziness or light-headedness
• Injection-site reactions (redness, itching, bruising or swelling)

Rarer but serious side effects include:

• Hypoglycaemia (low blood sugar)
• Gallbladder disease
• Severe allergic reaction (anaphylaxis)
• Acute pancreatitis
• Renal (kidney) impairment

Important safety notice: in January 2026 the MHRA strengthened its warnings about the risk of severe and fatal pancreatitis with GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, tirzepatide included. If you develop severe abdominal pain that does not settle, seek urgent medical attention [10].

▼ This medicine is subject to additional monitoring, which allows new safety information to be identified quickly. You can help by reporting any side effects you notice. Report side effects with the MHRA Yellow Card Scheme.

Tirzepatide alongside other medicines

Tell your doctor or pharmacist about everything you take - prescriptions, over-the-counter products, vitamins and herbal preparations. Because tirzepatide slows how quickly the stomach empties, it can change how fast oral medicines are absorbed [2]:

If you are unsure how your own medicines might interact, ask your bliss clinician before you begin.

What happens if you stop taking tirzepatide?

Regaining weight after stopping is common, and it is not a sign of failure. Obesity is a long-term condition, and tirzepatide works by actively holding appetite in check and changing how the body deals with food. Take that away and the physiological push to regain weight tends to reassert itself.

The SURMOUNT-4 trial looked at exactly this. People who came off tirzepatide after 36 weeks regained, on average, 14% of their body weight over the following year, while those who kept going lost a further 6.7% [8]. Most of those who stopped put back more than a quarter of what they had lost. The wider health gains - improvements in blood pressure, cholesterol and blood sugar - also tended to unwind in step with the weight that returned [9].

There is an encouraging caveat, though: on average, people who discontinued still finished the follow-up lighter than when they first started. Stopping does not wipe out every gain but holding on to long-term results does appear to depend on staying on treatment.

Getting the most from tirzepatide: diet, activity and alcohol

Tirzepatide is licensed to be used alongside a calorie-reduced diet and more physical activity - a genuine lifestyle change, not a substitute for one. The two together reliably beat either on its own. In SURMOUNT-1, everyone received structured diet and activity support with their medication, and that combination delivered far more weight loss than lifestyle changes alone [1].

Eating well

There is no set diet to follow on tirzepatide. What matters is a modest cut in calories, and most people find that easier than they expect: the medicine curbs appetite, slows stomach emptying, and prolongs fullness after meals, so smaller portions tend to satisfy [2]. A few habits that many people find useful:

• Eat regular, evenly spaced meals rather than skipping them - erratic eating can make nausea worse, especially during dose increases.
• Stay well hydrated - dehydration can amplify side effects, and it is a particular risk if you are dealing with nausea, vomiting or diarrhoea.
• Build a protein source into every meal; protein is more filling and helps protect lean muscle as you lose weight.
• Go easy on large, high-fat meals in the early weeks, since these tend to aggravate gastrointestinal side effects.

For tailored advice, speak to your Bliss nutritionist.

Moving more

Regular activity is a core part of treatment [2], and a mix of aerobic exercise like walking, cycling and swimming with some resistance training works best. One point worth knowing: as with any large weight loss, some lean muscle is lost alongside fat.

Analysis from SURMOUNT-1 found the ratio of muscle to fat lost was broadly similar to dieting alone [7], but because tirzepatide drives much greater total weight loss, the absolute amount of muscle lost can be higher. Resistance work helps offset that, which matters for your metabolic health and physical function over the long run. If you are new to exercise or have a condition that affects how active you can be, check with your healthcare provider before starting something new.

Drinking alcohol

The Mounjaro prescribing information sets no formal contraindication with alcohol, and moderate drinking is not off-limits [2] - but there are a couple of things to keep in mind. Nausea is one of the most common side effects, particularly while the dose is being stepped up, and alcohol is well known to make nausea and gut symptoms worse, so drinking (larger amounts especially) can make side effects harder to handle.

There is also an overlapping risk around pancreatitis: heavy drinking is an independent risk factor for it, and in January 2026 the MHRA updated its warnings about severe, necrotising (tissue-destroying) and fatal pancreatitis with tirzepatide and related medicines [10]. Avoiding heavy drinking is strongly advisable for anyone on this treatment. Most people can still enjoy alcohol in moderation without trouble - if you have specific concerns, raise them with your doctor or pharmacist.

This article offers general information about tirzepatide and is not a substitute for personal medical advice. Always speak to your prescriber or pharmacist before starting or changing any treatment.